Results 191 to 200 of about 24,870 (249)

Association of immune checkpoint inhibitor-induced bullous pemphigoid with underlying cancer type: A lack of association with cancer tissue <i>COL17A1</i> mutations and dysregulation. [PDF]

JID Innov
Chang RC, Olbrich H, Wang YF, Gainer H, Curkovic N, Walunas TL, Shiu J, Goyal P, Mansini AP, Ludwig RJ, Amber KT.   +10 more
europepmc   +1 more source

Bullous Diseases in the Perioperative Setting: Anesthetic Considerations. [PDF]

Cureus
Bokaee SA, Patel A.
europepmc   +1 more source

Ramipril-Induced Annular Bullous Pemphigoid: A Clinical Mimic of Linear IgA Dermatosis. [PDF]

Eurasian J Med
Karaca Ural Z.
europepmc   +1 more source

Linagliptin-Induced Bullous Pemphigoid: A Case Report and Comprehensive Literature Review. [PDF]

Cureus
Almutairi S, Alajmi FM, Albthali SM, Aldhafiri S.   +3 more
europepmc   +1 more source

Rituximab-Based Management of Autoimmune Blistering Diseases: A Case Series Highlighting Ocular and Systemic Presentations. [PDF]

Cureus
Vázquez-Folch SJ, Jiménez-Berríos GA, Vazquez VJ, Izquierdo N.   +3 more
europepmc   +1 more source

Omalizumab Therapy for Bullous Pemphigoid: A Case Report. [PDF]

Cureus
Alsantali A, AlZaidi RS, Alharbi B, Bakhsh AK, Zahrani AK, Alturkistani MI.   +5 more
europepmc   +1 more source

Clinical characteristics, management, and prognosis of pembrolizumab-induced immune-related oral mucositis. [PDF]

Front Immunol
Yu L, Li J, Tang Y.
europepmc   +1 more source

Bullous pemphigoid exhibiting Koebner phenomenon. [PDF]

Ann Med Surg (Lond)
Alhalees Z, Nagshabandi KN, Alsalhi A.
europepmc   +1 more source

Complement Activation May Drive the Pathogenicity of Anti-α6 and Anti-β4 Integrin Antibodies In Vivo. [PDF]

Biomolecules
Du G, Emtenani S, Niese D, Liu J, Gebauer F, Dunst NJ, Gökce A, Spaniol K, Groeber-Becker F, Šimunović J, Novokmet M, Geerling G, Amber KT, Hoffmann MH, Ludwig RJ, Bieber K, Goletz S, Zhou G, Schmidt E, Patzelt S.   +19 more
europepmc   +1 more source